查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1628052

2025-2034 年可生物降解骨移植聚合物市场机会、成长动力、产业趋势分析与预测

Biodegradable Bone Graft Polymers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年，全球可生物降解骨移植聚合物市场价值为7.331 亿美元，预计2025 年至2034 年复合年增长率为7.4%。的上升推动的。

聚合物技术的进步正在改善可生物降解骨移植物的生物相容性和机械性能，使其更有效地促进骨再生。对环保和永续医疗解决方案的需求也推动了可生物降解聚合物的采用，它为传统骨移植材料提供了对环境负责的替代品。此外，临床进步和监管部门的批准增强了人们对这些材料的信心，巩固了它们作为骨修復和再生中可行替代品的作用。

骨科和牙科手术的发生率不断增加，通常需要高效的骨再生解决方案，进一步支撑了市场。随着寻求骨折和牙种植等疾病治疗的患者数量持续增加，对创新移植材料的需求不断增长，推动了可生物降解骨移植聚合物市场的发展。

市场范围
开始年份 2024年
预测年份 2025-2034
起始值 7.331 亿美元
预测值 12亿美元
复合年增长率 7.4%

合成聚合物领域预计将大幅成长，预计到 2034 年市场价值将达到 11 亿美元，复合年增长率为 7.6%。合成的可生物降解聚合物，例如聚己内酯 (PCL) 和聚乳酸 (PLA)，由于其可客製化的特性而越来越受欢迎。这些材料可以客製化以提供特定的机械强度和降解率，使其成为骨科和牙科手术中精密应用的理想选择。相较之下，壳聚醣和胶原蛋白等天然聚合物因其优异的生物相容性和促进组织再生的能力而受到重视，反映了生物衍生材料在医疗应用中的更广泛趋势。

2024 年，联合重建领域占据市场领先地位，份额为 40.1%，价值 2.726 亿美元。由于人们越来越关注开发增强癒合和组织整合的聚合物，预计到 2034 年，该细分市场将以 7.7% 的复合年增长率成长。这些创新迎合了日益增长的患有关节相关问题的老龄化人口，凸显了可生物降解骨移植在促进更快恢復和更好结果方面的关键作用。

2034年，美国可生物降解骨移植聚合物市场预计将达到5.431亿美元，复合年增长率为7.4%。由于肌肉骨骼疾病发病率上升以及人口老化需要更多手术干预，骨科和牙科应用需求不断增长，推动了该地区的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
    • 影响价值链的因素
    • 利润率分析
    • 干扰
    • 未来展望
    • 製造商
    • 经销商
  • 供应商格局
  • 利润率分析
  • 重要新闻和倡议
  • 监管环境
  • 衝击力
  • 产业影响力
    • 成长动力
      • 骨科和牙科手术的发生率上升。
      • 对微创手术的需求不断增加。
      • 聚合物技术和生物相容性的进步。
    • 市场挑战
      • 监管障碍和漫长的审批流程。
  • 法规和市场影响
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场规模与预测：按聚合物分类，2021-2034 年

  • 主要趋势
  • 合成的
    • 解放军
    • PG
    • 聚己内酯
  • 自然的
    • 壳聚醣
    • 胶原

第 6 章：市场规模与预测：按应用划分，2021-2034 年

  • 主要趋势
  • 关节重建
  • 脊椎
  • 颅颚面
  • 骨科生物製剂
  • 牙科
  • 其他的

第 7 章：市场规模与预测：按地区划分，2021-2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • MEA
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 8 章：公司简介

  • BMG Incorporated
  • Corbion NV
  • Evonik
  • Foster Corporation
  • KLS Martin
  • Lactel Absorbable Polymers
  • Medtronic
  • NuVasive
  • Polysciences
  • Zimmer Biomet
简介目录
Product Code: 2283

The Global Biodegradable Bone Graft Polymers Market was valued at USD 733.1 million in 2024 and is expected to grow at a 7.4% CAGR from 2025 to 2034. This growth is primarily driven by the increasing demand for minimally invasive surgeries and the rising prevalence of bone-related conditions, which are creating a significant need for advanced regenerative treatments.

Advances in polymer technology are improving the biocompatibility and mechanical properties of biodegradable bone grafts, making them more effective for bone regeneration. The demand for eco-friendly and sustainable medical solutions is also fueling the adoption of biodegradable polymers, which offer an environmentally responsible alternative to traditional bone graft materials. Additionally, clinical advancements and regulatory approvals are boosting confidence in these materials, solidifying their role as a viable alternative in bone repair and regeneration.

The market is being further supported by the increasing incidence of orthopedic and dental procedures, which often require efficient bone regeneration solutions. As the number of patients seeking treatments for conditions like fractures and dental implants continues to rise, the demand for innovative grafting materials is growing, driving the market for biodegradable bone graft polymers.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$733.1 Million
Forecast Value$1.2 Billion
CAGR7.4%

The synthetic polymer segment is expected to grow significantly, with a projected market value of USD 1.1 billion by 2034 and a CAGR of 7.6%. Synthetic biodegradable polymers, such as polycaprolactone (PCL) and polylactic acid (PLA), are gaining popularity due to their customizable properties. These materials can be tailored to provide specific mechanical strength and degradation rates, making them ideal for precision applications in orthopedic and dental surgeries. In contrast, natural polymers like chitosan and collagen are valued for their excellent biocompatibility and ability to promote tissue regeneration, reflecting a broader trend toward biologically derived materials in medical applications.

The joint reconstruction segment led the market in 2024, holding a share of 40.1% and valued at USD 272.6 million. This segment is projected to grow at a CAGR of 7.7% through 2034, driven by the increasing focus on developing polymers that enhance healing and tissue integration. These innovations cater to a growing aging population with joint-related issues, highlighting the critical role of biodegradable bone grafts in promoting faster recovery and better outcomes.

U.S. biodegradable bone graft polymers market is expected to reach USD 543.1 million by 2034, expanding at a CAGR of 7.4%. Growth in this region is being fueled by rising demand in orthopedic and dental applications, driven by a higher incidence of musculoskeletal disorders and an aging population that requires more surgical interventions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
  • 3.7 Industry impact forces
    • 3.7.1 Growth drivers
      • 3.7.1.1 Rising incidence of orthopedic and dental surgeries.
      • 3.7.1.2 Increasing demand for minimally invasive procedures.
      • 3.7.1.3 Advancements in polymer technology and biocompatibility.
    • 3.7.2 Market challenges
      • 3.7.2.1 Regulatory hurdles and lengthy approval processes.
  • 3.8 Regulations & market impact
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Polymer, 2021-2034 (USD Million) (Tons)

  • 5.1 Key trends
  • 5.2 Synthetic
    • 5.2.1 PLA
    • 5.2.2 PG
    • 5.2.3 PCL
  • 5.3 Natural
    • 5.3.1 Chitosan
    • 5.3.2 Collagen

Chapter 6 Market Size and Forecast, By Application, 2021-2034 (USD Million) (Tons)

  • 6.1 Key trends
  • 6.2 Joint reconstruction
  • 6.3 Spine
  • 6.4 Craniomaxillofacial
  • 6.5 Orthobiologics
  • 6.6 Dental
  • 6.7 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2034 (USD Million) (Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 UK
    • 7.3.2 Germany
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 BMG Incorporated
  • 8.2 Corbion N.V.
  • 8.3 Evonik
  • 8.4 Foster Corporation
  • 8.5 KLS Martin
  • 8.6 Lactel Absorbable Polymers
  • 8.7 Medtronic
  • 8.8 NuVasive
  • 8.9 Polysciences
  • 8.10 Zimmer Biomet